<?xml version="1.0" encoding="UTF-8"?>
<title-group>
 <article-title>Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study</article-title>
</title-group>
